Julia D. Maltzman - 31 Jan 2025 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Medical Officer
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
04 Feb 2025, 16:40:14 UTC
Previous filing
23 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACET Stock Option (Right to Buy) Award $0 +750,000 $0.000000 750,000 31 Jan 2025 Common Stock 750,000 $0.8850 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest on December 7, 2025, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.